The Pristine Post-Market Study

Clinical trial NCT05228132 · TERMINATED

Trial details

NCT number: NCT05228132
Sponsor: C. R. Bard
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Kidney Failure, Chronic Hemodialysis Complication Hemodialysis Catheter Infection Hemodialysis Access Failure Central Venous Catheter Related Bloodstream Infection End Stage Renal Disease

Start date: 2022-05-16
Primary completion: 2022-09-21
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.